이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1994. 10. 14.1 분 읽기
National Institute of Mental Health; Licensing Opportunity and/or Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Use of Retroviral Vectors With Gibbon Ape Leukemia Virus (GaLV) Components
로컬 자동 번역 · 원본 출처 언어
요약
The National Institutes of Health is seeking licensees and/or CRADA partners for the further development, evaluation, and commercialization of novel retroviral vectors with Gibbon Ape Leukemia Virus (GaLV) components. The invention claimed in the following patent application is available for either exclusive or non-exclusive licensing (in accordance with 35 U.S.C. 207 and 37 CFR Part 404) and/or further development under a CRADA for important clinical and research applications as described below in the Supplementary Information:
원본 출처 언어: Federal Register — Health and Human Services원문 발표 열기 →